OCULAR THERAPEUTIX, INC Investment Income, Net
OCULAR THERAPEUTIX, INC (OCUL) reported Investment Income, Net of $5.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-03
- OCULAR THERAPEUTIX, INC investment income, net for the quarter ending 2026-06-30 was $5.45M, a 57.71% increase year-over-year.
- OCULAR THERAPEUTIX, INC investment income, net for the quarter ending 2026-03-31 was $6.05M, a 58.13% increase year-over-year.
- OCULAR THERAPEUTIX, INC investment income, net for the quarter ending 2025-12-31 was $7.34M, a 57.20% increase year-over-year.
- OCULAR THERAPEUTIX, INC investment income, net for the quarter ending 2025-09-30 was $3.73M, a 34.04% decline year-over-year.
- OCULAR THERAPEUTIX, INC investment income, net for fiscal 2025 was $18.36M, a 9.50% decline from fiscal 2024.
- OCULAR THERAPEUTIX, INC investment income, net for fiscal 2024 was $20.28M, a 409.21% increase from fiscal 2023.
- OCULAR THERAPEUTIX, INC investment income, net for fiscal 2023 was $3.98M, a 399.12% increase from fiscal 2022.
- OCULAR THERAPEUTIX, INC investment income, net for fiscal 2022 was $798.00K, a 2318.18% increase from fiscal 2021.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.45M 10-Q · filed 2026-08-03 | $11.50M 10-Q · filed 2026-08-03 | $18.84M derived: sum of 3 quarters · filed 2026-08-03 | $22.57M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $6.05M 10-Q · filed 2026-05-05 | $13.39M derived: sum of 2 quarters · filed 2026-05-05 | $17.12M derived: sum of 3 quarters · filed 2026-05-05 | $20.58M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $11.07M derived: sum of 2 quarters · filed 2026-02-05 | $14.53M derived: sum of 3 quarters · filed 2026-08-03 | $18.36M 10-K · filed 2026-02-05 |
| 2025-09-30 | $3.73M 10-Q · filed 2025-11-04 | $7.18M derived: sum of 2 quarters · filed 2026-08-03 | $11.01M 10-Q · filed 2025-11-04 | $15.68M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $3.46M 10-Q · filed 2026-08-03 | $7.28M 10-Q · filed 2026-08-03 | $11.95M derived: sum of 3 quarters · filed 2026-08-03 | $17.61M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $3.83M 10-Q · filed 2026-05-05 | $8.50M derived: sum of 2 quarters · filed 2026-05-05 | $14.15M derived: sum of 3 quarters · filed 2026-05-05 | $20.19M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $10.32M derived: sum of 2 quarters · filed 2026-02-05 | $16.36M derived: sum of 3 quarters · filed 2026-02-05 | $20.28M 10-K · filed 2026-02-05 |
| 2024-09-30 | $5.65M 10-Q · filed 2025-11-04 | $11.69M derived: sum of 2 quarters · filed 2025-11-04 | $15.61M 10-Q · filed 2025-11-04 | $17.07M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-06-30 | $6.04M 10-Q · filed 2025-08-05 | $9.96M 10-Q · filed 2025-08-05 | $11.42M derived: sum of 3 quarters · filed 2026-02-05 | $12.63M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-03-31 | $3.92M 10-Q · filed 2025-05-05 | $5.38M derived: sum of 2 quarters · filed 2026-02-05 | $6.59M derived: sum of 3 quarters · filed 2026-02-05 | $7.34M derived: sum of 4 quarters · filed 2026-02-05 |
| 2023-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $2.67M derived: sum of 2 quarters · filed 2026-02-05 | $3.42M derived: sum of 3 quarters · filed 2026-02-05 | $3.98M 10-K · filed 2026-02-05 |
| 2023-09-30 | $1.21M 10-Q · filed 2024-11-14 | $1.96M derived: sum of 2 quarters · filed 2024-11-14 | $2.52M 10-Q · filed 2024-11-14 | $2.95M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $748.00K 10-Q · filed 2024-08-07 | $1.31M 10-Q · filed 2024-08-07 | $1.73M derived: sum of 3 quarters · filed 2025-03-03 | $2.02M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $563.00K 10-Q · filed 2024-05-07 | $986.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.27M derived: sum of 3 quarters · filed 2025-03-03 | $1.34M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $423.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $708.00K derived: sum of 2 quarters · filed 2025-03-03 | $781.00K derived: sum of 3 quarters · filed 2025-03-03 | $798.00K 10-K · filed 2025-03-03 |
| 2022-09-30 | $285.00K 10-Q · filed 2023-11-07 | $358.00K derived: sum of 2 quarters · filed 2023-11-07 | $375.00K 10-Q · filed 2023-11-07 | $382.00K derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | $73.00K 10-Q · filed 2023-08-07 | $89.00K 10-Q · filed 2023-08-07 | $97.00K derived: sum of 3 quarters · filed 2024-03-11 | $104.00K derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | $18.00K 10-Q · filed 2023-05-08 | $24.00K derived: sum of 2 quarters · filed 2024-03-11 | $31.00K derived: sum of 3 quarters · filed 2024-03-11 | $39.00K derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $13.00K derived: sum of 2 quarters · filed 2024-03-11 | $21.00K derived: sum of 3 quarters · filed 2024-03-11 | $33.00K 10-K · filed 2024-03-11 |
| 2021-09-30 | $7.00K 10-Q · filed 2022-11-07 | $15.00K derived: sum of 2 quarters · filed 2022-11-07 | $27.00K 10-Q · filed 2022-11-07 | $33.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $8.00K 10-Q · filed 2022-08-08 | $20.00K 10-Q · filed 2022-08-08 | $26.00K derived: sum of 3 quarters · filed 2023-03-06 | $32.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $12.00K 10-Q · filed 2022-05-09 | $18.00K derived: sum of 2 quarters · filed 2023-03-06 | $24.00K derived: sum of 3 quarters · filed 2023-03-06 | $41.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $12.00K derived: sum of 2 quarters · filed 2023-03-06 | $29.00K derived: sum of 3 quarters · filed 2023-03-06 | $168.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | $6.00K 10-Q · filed 2021-11-08 | $23.00K derived: sum of 2 quarters · filed 2021-11-08 | $162.00K 10-Q · filed 2021-11-08 | $375.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $17.00K 10-Q · filed 2021-08-09 | $156.00K 10-Q · filed 2021-08-09 | $369.00K derived: sum of 3 quarters · filed 2022-02-28 | $677.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $139.00K 10-Q · filed 2021-05-05 | $352.00K derived: sum of 2 quarters · filed 2022-02-28 | $660.00K derived: sum of 3 quarters · filed 2022-02-28 | $1.04M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $521.00K derived: sum of 2 quarters · filed 2022-02-28 | $900.00K derived: sum of 3 quarters · filed 2022-02-28 | $1.23M 10-K · filed 2022-02-28 |
| 2019-09-30 | $308.00K 10-Q · filed 2020-11-05 | $687.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.02M 10-Q · filed 2020-11-05 | $1.27M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $379.00K 10-Q · filed 2020-08-07 | $708.00K 10-Q · filed 2020-08-07 | $966.00K derived: sum of 3 quarters · filed 2020-08-07 | $1.20M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $329.00K 10-Q · filed 2020-05-08 | $587.00K derived: sum of 2 quarters · filed 2020-05-08 | $817.00K derived: sum of 3 quarters · filed 2020-05-08 | $1.03M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $258.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $488.00K derived: sum of 2 quarters · filed 2020-03-12 | $703.00K derived: sum of 3 quarters · filed 2020-03-12 | $879.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $230.00K 10-Q · filed 2019-11-12 | $445.00K derived: sum of 2 quarters · filed 2019-11-12 | $621.00K 10-Q · filed 2019-11-12 | $725.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $215.00K 10-Q · filed 2019-08-07 | $391.00K 10-Q · filed 2019-08-07 | $495.00K derived: sum of 3 quarters · filed 2020-03-12 | $610.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $176.00K 10-Q · filed 2019-05-10 | $280.00K derived: sum of 2 quarters · filed 2020-03-12 | $395.00K derived: sum of 3 quarters · filed 2020-03-12 | $508.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $219.00K derived: sum of 2 quarters · filed 2020-03-12 | $332.00K derived: sum of 3 quarters · filed 2020-03-12 | $424.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $115.00K 10-Q · filed 2018-11-07 | $228.00K derived: sum of 2 quarters · filed 2018-11-07 | $320.00K 10-Q · filed 2018-11-07 | $388.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $113.00K 10-Q · filed 2018-08-07 | $205.00K 10-Q · filed 2018-08-07 | $273.00K derived: sum of 3 quarters · filed 2019-03-07 | $342.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $92.00K 10-Q · filed 2018-05-08 | $160.00K derived: sum of 2 quarters · filed 2019-03-07 | $229.00K derived: sum of 3 quarters · filed 2019-03-07 | $309.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $137.00K derived: sum of 2 quarters · filed 2019-03-07 | $217.00K derived: sum of 3 quarters · filed 2019-03-07 | $304.00K 10-K · filed 2019-03-07 |
| 2016-09-30 | $69.00K 10-Q · filed 2017-11-07 | $149.00K derived: sum of 2 quarters · filed 2017-11-07 | $236.00K 10-Q · filed 2017-11-07 | $281.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $80.00K 10-Q · filed 2016-08-09 | $167.00K 10-Q · filed 2017-08-08 | $212.00K derived: sum of 3 quarters · filed 2018-03-08 | $265.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $87.00K 10-Q · filed 2017-05-05 | $132.00K derived: sum of 2 quarters · filed 2018-03-08 | $185.00K derived: sum of 3 quarters · filed 2018-03-08 | $213.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $98.00K derived: sum of 2 quarters · filed 2018-03-08 | $126.00K derived: sum of 3 quarters · filed 2018-03-08 | $166.00K 10-K · filed 2018-03-08 |
| 2015-09-30 | $53.00K 10-Q · filed 2016-11-09 | $81.00K derived: sum of 2 quarters · filed 2016-11-09 | $121.00K 10-Q · filed 2016-11-09 | $121.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | $28.00K 10-Q · filed 2016-08-09 | $68.00K 10-Q · filed 2016-08-09 | $68.00K derived: sum of 3 quarters · filed 2017-03-10 | $73.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | $40.00K 10-Q · filed 2016-05-10 | $40.00K derived: sum of 2 quarters · filed 2017-03-10 | $45.00K derived: sum of 3 quarters · filed 2017-03-10 | $46.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $5.00K derived: sum of 2 quarters · filed 2017-03-10 | $6.00K derived: sum of 3 quarters · filed 2017-03-10 | $7.00K 10-K · filed 2017-03-10 |
| 2014-09-30 | $5.00K 10-Q · filed 2015-11-10 | $6.00K derived: sum of 2 quarters · filed 2015-11-10 | $7.00K 10-Q · filed 2015-11-10 | |
| 2014-06-30 | $1.00K 10-Q · filed 2015-08-10 | $2.00K 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $1.00K 10-Q · filed 2015-05-15 | |||
| 2013-12-31 | $13.00K 10-K · filed 2016-03-10 | |||
| 2012-12-31 | $4.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |